Expression of cadherins and catenins in oral epithelial dysplasia and squamous cell carcinoma

Journal of Oral Pathology and Medicine

Volumn 27, Issue 7, 1998, Pages 308-317

  Williams, H K ^a,c   Sanders, D S A ^b   Jankowski, J A Z ^b   Landini, G ^a   Brown, A M S ^b  

^a UNIVERSITY OF BIRMINGHAM   (United Kingdom)

^b UNIVERSITY HOSPITALS BIRMINGHAM NHS FOUNDATION TRUST   (United Kingdom)

^c BIRMINGHAM DENTAL HOSPITAL   (United Kingdom)

Author keywords

Cadherin; CAMs; Catenin; Dysplasia; Oral; Squamous cell carcinoma

Indexed keywords

EID: 0032145470     PISSN: 09042512     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1600-0714.1998.tb01962.x     Document Type: Article

References (57)

1. TAKEICHI M. Cadherin cell adhesion receptors as a morphogenetic regulator. Science 1991; 251: 1451-5.
2. LEWIS JE, JENSEN PJ, JOHNSON KR, WHEELOCK MJ. E-cadherin mediates adherens junction organisation through protein kinase C. J Cell Sci 1995; 108: 3615-21.
3. Jou TS, STEWART DB, STAPPERT J, NELSON WJ, MARRS JA. Genetic and biochemical dissection of protein linkages in the cadherin-catenin complex. Proc Natl Acad Sci USA 1995; 92: 5067-71.
4. HINCK L, NATHKE IS, PAPKOFF J, NELSON WJ. Dynamics of cadherin/catenin complex formation: novel protein interactions and pathways of complex assembly. J Cell Biol 1994; 125: 1327-40.
5. STEINBERG MS, TAKEICHI M. Experimental specification of cell sorting, tissue spreading and specific spatial patterning by quantitative differences in cadherin expression. Proc Natl Acad Sci USA 1994; 91: 206-9.
6. TAKEICHI M. Cadherins in cancer: implications for invasion and metastases. Curr Opin Cell Biol 1993; 5: 806-11.
7. LEVI G, GUMBINER B, THIERY JP. The distribution of E-cadherin during Xenopus laevis development. Development 1991; 111: 159-69.
8. THOMA Y, YAMASHIMA T, YAMASHITA J. Immunohistochemical localization of cell adhesion molecule epithelial cadherin in human arachnoid villi and meningiomas. Cancer Res 1992; 52: 1981-7.
9. TANG A, ELLER MS, HARA M, YAAR M, HIROHASHI S, GILCHREST BA. E-cadherin is the major mediator of human melanocyte adhesion to keratinocytes in vitro. J Cell Sci 1994; 107: 983-92.
10. TAKEICHI M. The cadherins: cell-cell adhesion molecules controlling animal morphogenesis. Development 1988; 102: 639-55.
11. DOGAN A, WANG ZD, SPENCER J. E-cadherin expression in intestinal epithelium. J Clin Pathol 1995; 48: 143-6.
12. MAREEL M, BRACKE M, VAN ROY F. Invasion promoter versus invasion suppressor molecules: the paradigm of E-cadherin. Mol Biol Rep 1994; 19: 45-67.
13. SCHIPPER JH, FRIXEN UH, BEHRENS J, UNGER A, JAHNKE K, BIRCHMEIER W. E-cadherin in squamous cell carcinomas of head and neck: inverse correlation with tumour dedifferentiation and lymph node metastases. Cancer Res 1991; 51: 6328-37.
14. SORSCHER SM, RUSSACK V, CAGLE M, et al. Immunolocalization of E-cadherin in head and neck cancer. Arch Pathol Lab Med 1995; 119: 82-4.
15. DORUDI S, SHEFFIELD JP, POULSOM R, NORTHOVER JMA, HART IR. E-cadherin expression in colorectal cancer. An immunocytochemical and in situ hybridisation study. Am J Pathol 1993; 142: 981-6.
16. JANKOWSKI JA, NEWMAN PM, KANDEMIR O, HIRANO S, TAKEICHI M, PIGNATELLI M. Differential expression of E-cadherin in normal, metaplastic and dysplastic oesophageal mucosa: a putative biomarker. Int J Oncology 1994; 4: 441-8.
17. KRISHNADATH KK, TILANUS HW, VAN BLANKENSTEIN M, et al Reduced expression of the cadherin-catenin complex in oesophageal adenocarcinoma correlates with poor prognosis. J Pathol 1997; 182: 331-8.
18. GAGLIARDI G, KANDEMIR P, LIU D, et al. Changes in E-cadherin immunoreactivity in the adenoma-carcinoma sequence of the large bowel. Virchows Arch 1995; 426: 149-54.
19. VESSEY CJ, WILDING J, FOLARIN N, et al. Altered expression and function of E-cadherin in cervical intraepithelial neoplasia and invasive squamous cell carcinoma. J Pathol 1995; 176: 151-9.
20. SHIOZAKI H, IIHARA K, OKA H, et al. Immunohistochemical detection of α catenin expression in human cancers. Am J Pathol 1994; 144: 667-74.
21. OCHIAI A, AKIMOTO S, SHIMOYAMA Y, NAGAFUCHI A, TSUKITA S, HIROHASHI S, Frequent loss of α-catenin expression in scirrhous carcinomas with scattered cell growth. Jpn J Cancer Res 1994; 84: 266-73.
22. HASHIZUME R, KOIZUMI H, IHARA A, OHTA T, UCHIKOSHI T. Expression of β catenin in normal breast tissue and breast carcinoma: a comparative study with epithelial cadherin and α-catenin. Histopathology 1996; 29: 139-46.
23. TAKAYAMA T, SHIOZAKI H, SHIBAMOTO S, et al. β catenin expression in human cancers. Am J Pathol 1996; 148: 39-46.
24. BECKER KF, ATKINSON MJ, REICH U, et al. E-cadherin gene mutations provide clues to diffuse type gastric carcinomas. Cancer Res 1994; 54: 3845-52.
25. BERX G, CLETON-JANSEN A, NOLLET F, et al. E-cadherin is a tumour-invasion suppressor gene mutated in human lobular breast cancers. EMBO J 1995; 14: 6107-15.
26. ILYAS M, TOMLINSON IPM. The interactions of APC, E-cadherin and β-catenin in tumour development and progression. J Pathol 1997; 182: 128-37.
27. SMITH MEF, PIGNATELLI M. The molecular histology of neoplasia: the role of the cadherin/catenin complex. Histopathology 1997; 31: 107-11.
28. MORTON RA, EWING CM, NAGAFUCHI A, TSUKITA S, ISAACS WB. Reduction of E-cadherin levels and deletion of the α-catenin gene in human prostate cancer cells. Cancer Res 1993; 53: 3585-90.
29. BREEN E, CLARKE A, STEELE G, MERCURIO AM. Poorly differentiated colon carcinoma cell lines deficient in α-catenin expression express high levels of surface E-cahderin but lack Ca[2+] dependent cell-cell adhesion. Cell Adhes Commun 1993; 1: 239-50.
30. BEHRENS J, VAKAET L, FRII R, et al. Loss of epithelial differentiation and gain of invasiveness correlates with tyrosine phosphorylation of the E-cadherin/β catenin complex in cells transformed with a temperature-sensitive v-SRC gene. J Cell Biol 1993; 120: 757-66.
31. PIGNATELLI M. Mechanisms of cell adhesion during epithelial restitution in the gastrointestinal tract. Yale J Biol Med 1997; 69: 131-5.
32. FEARON ER, VOGELSTEIN B. A genetic model for colorectal tumorigenesis. Cell 1990; 61: 759-67.
33. HOLLSTEIN M, SIDRANSKY D, VOGELSTEIN B, HARRIS CC. p53 mutations in human cancers. Science 1991; 253: 49-53.
34. GONZÁLEZ MV, ARTIMEZ ML, RODRIGO L, et al. Mutation analysis of the p53, APC and p16 genes in the Barrett's oesophagus, dysplasia and adenocarcinoma. J Clin Pathol 1997; 50: 212-7.
35. SLOOTWEG PJ, KOOLE R, HORDIJK GJ. The presence of p53 protein in relation to Ki-67 as cellular proliferation marker in head-neck squamous cell carcinoma and adjacent dysplastic mucosa. Eur J Cancer B Oral Oncol 1994; 30: 138-41.
36. SHIN DM, KIM J, RO JY, et al. Activation of p53 gene expression in premalignant lesions during head and neck tumourgenesis. Cancer Res 1994; 54: 321-6.
37. SAKATA K. Alterations of tumour suppressor genes and the H-ras oncogene in oral squamous cell carcinoma. J Oral Pathol Med 1996; 25: 302-7.
38. MATSUDA H, KONISHI N, HIASA Y, et al. Alterations of p16/CDKN2, p53 and ras genes in oral squamous cell carcinomas and premalignant lesions. J Oral Pathol Med 1996; 25: 232-8.
39. SARANATH D, BHOITE LT, SANGHARI V, MEHTA AR, DEO M Loss of allelic heterozygosity at the Harvey ras locus in human oral carcinomas. J Cancer Res Clin Oncol 1991; 117: 484-8.
40. CHANG SE, BHATIA P, JOHNSON PR, MCCORMICK F, YOUNG B, HIORNS L. Ras mutations in United Kingdom examples of oral malignancies are infrequent, Int J Cancer 1991; 48: 409-12.
41. HUANG JS, CHIANG CP, KOK SH, KUO YS, Kuo MYP. Loss of heterozygosity of APC and MCC genes in oral squamous cell carcinoma in Taiwan. J Oral Path Med 1997; 26: 322-6.
42. HODIVALA KJ, WATT FM. Evidence that cadherins play a role in the downregulation of integrin expression that occurs during keratinocyte terminal differentiation. J Cell Biol 1994; 124: 589-600.
43. JANKOWSKI J, FORBES A, CRUIKSHIANK N, et al. Classical cadherins as morphoregulators in human colitis: in vivo and in vitro. Gut 1997; 40: (Suppl: 1): F 308.
44. DOBSON H, PIGNATELLI M, HOPWOOD D, DARRIGO C. Cell adhesion molecules in oesophageal epithelium. Gut 1994; 35: 1343-7.
45. JULIANO RL, HASKILL S. Signal transduction from the extracellular matrix. J Cell Biol 1993; 120: 577-85.
46. 4 integrin subunits coincides with loss of basement membrane components in oral squamous cell carcinomas. J Pathol 1993; 197: 183-90.
47. JONES J, SUGIYAMA M, WATT FM, SPEIGHT PM. Integrin expression in normal, hyperplastic, dysplastic and malignant oral epithelium. J Pathol 1993; 169: 235-43.
48. v integrins in oral squamous carcinomas. J Oral Pathol Med 1997; 26: 63-8.
49. JOHNSON KR, LEWIS JE, WAHL J, SOLAR AP, KNUDSON KA, WHEELOCK MJ. P & E cadherin are in separate complexes in cells expressing both cadherms. Exp Cell Res 1993; 207: 252-60.
50. FRIXEN UH, BEHRENS J, SACHS M, et al. E-cadherin-mediated cell-cell adhesion prevents invasiveness of human carcinoma cells. J Cell Biol 1991; 133: 173-85.
51. VLEMINCKX K, VAKAET L, MAREEL M, FIERS W, VAN ROY F. Genetic manipulation of E-cadherin expression by epithelial tumour cells reveals an invasion suppressor role. Cell 1991; 66: 107-19.
52. BURGE SM, SCHOMBERG KH. Adhesion molecules and related proteins in Darier's disease and Ilailey-Hailey disease. Br J Dermatol 1992; 127: 335-43.
53. BURGE SM, WILSON CL, DEAN D, WOJNAROWSKA F. An immunohistological study of desmosomal components in pemphigus. Br J Dermatol 1993; 128: 363-70.
54. DOWNER CS, SPEIGHT PM. E-cadherin expression in normal, hyperplastic and malignant oral epithelium. Eur J Cancer B Oral Oncol 1993; 29: 303-5.
55. OKA H, SHIOZAKI H, KOBAYASHI K, et al. Expression of E-cadherin adhesion molecules in human breast tissues and its relationship to metastasis. Cancer Res 1993; 53: 1696-701.
56. TAKAYAMA T, SHIOZAKI H, SHIBAMOTO S, et al. Beta catenin expression in human cancers. Am J Pathol 1996; 148: 39-46.
57. COWLEY GP, SMITH MEF. Modulation of E-cadherin expression and morphological phenotype in the intravascular component of adenocarcinomas. Int J Cancer 1995; 60: 325-9.